EDWARDS LIFESCIENCES CORP (1EW.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1EW - US28176E1082 - Common Stock
73.47 EUR
+6.99 (+10.51%)
We assign a fundamental rating of 7 out of 10 to 1EW. 1EW was compared to 68 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making 1EW a very profitable company, without any liquidiy or solvency issues. 1EW is quite expensive at the moment. It does show a decent growth rate. These ratings could make 1EW a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
1EW had positive earnings in the past year.
1EW had a positive operating cash flow in the past year.
Each year in the past 5 years 1EW has been profitable.
In the past 5 years 1EW always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.31%, 1EW belongs to the top of the industry, outperforming 90.16% of the companies in the same industry.
The Return On Equity of 1EW (13.40%) is better than 78.69% of its industry peers.
The Return On Invested Capital of 1EW (12.50%) is better than 88.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1EW is significantly above the industry average of 9.73%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROIC | 12.5% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
1.3 Margins
1EW's Profit Margin of 23.25% is amongst the best of the industry. 1EW outperforms 93.44% of its industry peers.
In the last couple of years the Profit Margin of 1EW has grown nicely.
With an excellent Operating Margin value of 27.73%, 1EW belongs to the best of the industry, outperforming 98.36% of the companies in the same industry.
In the last couple of years the Operating Margin of 1EW has remained more or less at the same level.
1EW's Gross Margin of 78.19% is amongst the best of the industry. 1EW outperforms 91.80% of its industry peers.
In the last couple of years the Gross Margin of 1EW has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1EW is creating value.
The number of shares outstanding for 1EW has been reduced compared to 1 year ago.
Compared to 5 years ago, 1EW has less shares outstanding
Compared to 1 year ago, 1EW has an improved debt to assets ratio.
2.2 Solvency
1EW has an Altman-Z score of 12.38. This indicates that 1EW is financially healthy and has little risk of bankruptcy at the moment.
1EW has a better Altman-Z score (12.38) than 95.08% of its industry peers.
1EW has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
1EW has a Debt to FCF ratio of 0.75. This is amongst the best in the industry. 1EW outperforms 93.44% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that 1EW is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.06, 1EW belongs to the best of the industry, outperforming 86.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Altman-Z | 12.38 |
ROIC/WACC1.45
WACC8.62%
2.3 Liquidity
1EW has a Current Ratio of 4.00. This indicates that 1EW is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of 1EW (4.00) is better than 91.80% of its industry peers.
A Quick Ratio of 3.29 indicates that 1EW has no problem at all paying its short term obligations.
The Quick ratio of 1EW (3.29) is better than 91.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 |
3. Growth
3.1 Past
1EW shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.75%.
The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
Looking at the last year, 1EW shows a small growth in Revenue. The Revenue has grown by 4.67% in the last year.
Measured over the past years, 1EW shows a small growth in Revenue. The Revenue has been growing by 4.58% on average per year.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
3.2 Future
1EW is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.50% yearly.
The Revenue is expected to grow by 8.55% on average over the next years. This is quite good.
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.95, 1EW can be considered very expensive at the moment.
1EW's Price/Earnings ratio is in line with the industry average.
1EW's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.19.
With a Price/Forward Earnings ratio of 28.93, 1EW can be considered very expensive at the moment.
1EW's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of 1EW to the average of the S&P500 Index (23.92), we can say 1EW is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.95 | ||
| Fwd PE | 28.93 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1EW is valued a bit more expensive than 60.66% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1EW is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 61.42 | ||
| EV/EBITDA | 25.01 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1EW does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of 1EW may justify a higher PE ratio.
PEG (NY)77.74
PEG (5Y)4.62
EPS Next 2Y5.67%
EPS Next 3Y7.57%
5. Dividend
5.1 Amount
No dividends for 1EW!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1EW (11/11/2025, 7:00:00 PM)
73.47
+6.99 (+10.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap42.63B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts77.67
Price Target81.34 (10.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-4.64%
Revenue beat(12)2
Avg Revenue beat(12)-3.41%
Revenue beat(16)2
Avg Revenue beat(16)-3.45%
PT rev (1m)5.02%
PT rev (3m)5.02%
EPS NQ rev (1m)-1.51%
EPS NQ rev (3m)-1.51%
EPS NY rev (1m)4.19%
EPS NY rev (3m)4.19%
Revenue NQ rev (1m)2.72%
Revenue NQ rev (3m)2.72%
Revenue NY rev (1m)3.45%
Revenue NY rev (3m)3.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.95 | ||
| Fwd PE | 28.93 | ||
| P/S | 8.35 | ||
| P/FCF | 61.42 | ||
| P/OCF | 48.3 | ||
| P/B | 4.81 | ||
| P/tB | 6.72 | ||
| EV/EBITDA | 25.01 |
EPS(TTM)2.23
EY3.04%
EPS(NY)2.54
Fwd EY3.46%
FCF(TTM)1.2
FCFY1.63%
OCF(TTM)1.52
OCFY2.07%
SpS8.8
BVpS15.27
TBVpS10.93
PEG (NY)77.74
PEG (5Y)4.62
Graham Number27.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 13.4% | ||
| ROCE | 13.97% | ||
| ROIC | 12.5% | ||
| ROICexc | 18.63% | ||
| ROICexgc | 29.56% | ||
| OM | 27.73% | ||
| PM (TTM) | 23.25% | ||
| GM | 78.19% | ||
| FCFM | 13.59% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)15.82%
ROIC(5y)17.27%
ROICexc(3y)20.51%
ROICexc(5y)22.13%
ROICexgc(3y)29.09%
ROICexgc(5y)31.03%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.75 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 138.79% | ||
| Cap/Sales | 3.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.86% | ||
| Profit Quality | 58.45% | ||
| Current Ratio | 4 | ||
| Quick Ratio | 3.29 | ||
| Altman-Z | 12.38 |
F-Score6
WACC8.62%
ROIC/WACC1.45
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.76%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%
EDWARDS LIFESCIENCES CORP / 1EW.MI FAQ
Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?
ChartMill assigns a fundamental rating of 7 / 10 to 1EW.MI.
What is the valuation status of EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (1EW.MI). This can be considered as Overvalued.
How profitable is EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
EDWARDS LIFESCIENCES CORP (1EW.MI) has a profitability rating of 8 / 10.
What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (1EW.MI) is 32.95 and the Price/Book (PB) ratio is 4.81.
What is the expected EPS growth for EDWARDS LIFESCIENCES CORP (1EW.MI) stock?
The Earnings per Share (EPS) of EDWARDS LIFESCIENCES CORP (1EW.MI) is expected to grow by 0.42% in the next year.